Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

Todd Meyer, Liza Robles‐Carrillo, Theresa Robson et al. · Journal of Thrombosis and Haemostasis · 2008 · 154 citations · Full text

Medicine, Hematology, Immunology +14

A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM)

Timothy F. Cloughesy, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2008 · 145 citations

Medicine, Oncology, Pharmacology +16

Platelets Take Up the Monoclonal Antibody Bevacizumab

Henk M.W. Verheul, Martijn P. Lolkema, David Z. Qian et al. · Clinical Cancer Research · 2007 · 112 citations

Medicine, Hematology, Oncology +17

Safety of anticoagulation use and bevacizumab in patients with glioma

Phioanh L. Nghiemphu, Richard M. Green, Whitney B. Pope et al. · Neuro-Oncology · 2008 · 92 citations · Full text

Medicine, Oncology, Radiology +17

Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-00211

H. Ian Robins, Minhee Won, Wendy Seiferheld et al. · Neuro-Oncology · 2006 · 60 citations · Full text

Medicine, Oncology, Radiation Oncology +16